An introduction to the Endocrine Society Clinical Practice Guideline on treatment of symptoms of the menopause
Open Access
- 1 March 2016
- journal article
- editorial
- Published by Taylor & Francis in Post Reproductive Health
- Vol. 22 (1) , 6-8
Abstract
Treatment of symptoms of menopause remains a challenge for many health care practitioners. In an effort to facilitate this process, the Endocrine Society convened an international Task Force of menopause experts to review the relevant clinical evidence and formulate practical recommendations for relieving the most common menopausal symptoms. The result is a comprehensive evidence-based guideline, which emphasizes an individualized approach to alleviate bothersome vasomotor symptoms and those related to postmenopausal changes of the vagina and urinary tract. Therapies including estrogen, either alone or in combination with progestogen or bazedoxifene, tibolone, antidepressants, gabapentin, as well as complementary approaches are discussed. In this commentary, the chairs of the Task Force highlight the organization and content of the guideline and the processes involved in its development.Keywords
This publication has 6 references indexed in Scilit:
- Treatment of Symptoms of the Menopause: An Endocrine Society Clinical Practice GuidelineThe Journal of Clinical Endocrinology & Metabolism, 2015
- Genitourinary syndrome of menopauseMenopause, 2014
- Menopausal Hormone Therapy and Health Outcomes During the Intervention and Extended Poststopping Phases of the Women’s Health Initiative Randomized TrialsJAMA, 2013
- Executive Summary of the Stages of Reproductive Aging Workshop + 10: Addressing the Unfinished Agenda of Staging Reproductive AgingThe Journal of Clinical Endocrinology & Metabolism, 2012
- Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009Menopause, 2011
- Postmenopausal Hormone Therapy: An Endocrine Society Scientific StatementThe Journal of Clinical Endocrinology & Metabolism, 2010